Camlin Fine Sciences Ltd (CAMLINFINE) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- The board approved a INR 250 crore rights issue to resolve a severe liquidity crisis that has been eroding margins by an estimated 4% quarterly.
- Management has abandoned its full-year guidance but projects a sharp Q4 FY27 turnaround, targeting INR 600 crore revenue and over 10% EBITDA margin post-funding.
- The company expects to achieve a 1,000 MT quarterly sales volume for vanillin starting in Q4 FY27 as illegal Chinese imports are curbed in key markets.
Performance Overview
- The company reported an encouraging financial performance, heavily impacted by significant liquidity constraints which hampered growth and compressed margins.
- To address liquidity challenges and fund working capital, the board has approved a rights issue of approximately INR 250 crores.
- The diphenol plant remained shut down since May 2026 due to economically unviable input costs, with cheaper imports available from China.
- Performance in the Aroma segment declined significantly due to a strategic shift from ethyl vanillin to methyl vanillin and underutilization of the plant.
- The Specialty Ingredients business, particularly Blends, demonstrated resilience, holding its market position despite the inability to push for growth due to working capital limitations.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.